Will the Future of Innovation be Person-Centered?

Adimika Arthur, MPH is an experienced clinical epidemiologist and hospital/health system executive. She uniquely brings her population health, public hospital expertise and focus on improving health equity and access to quality care for vulnerable populations. She serves as the founding Executive Director for HealthTech for Medicaid (HT4M). HT4M is a collaborative convening of payers, providers, policymakers and innovative entrepreneurs collectively advocating for health equity and improvement of the Medicaid program on a national scale. This collective of advocates believe that with the strategic injection of technology and innovation into the Medicaid ecosystem and strives to be a bold, action-oriented, and inclusive network working to ensure critical new technology reaches Medicaid enrollees and other traditionally disadvantaged populations. Adimika is a public health leader, hospital executive and humanitarian who holds numerous certificates and awards. She combines her love of mentoring, servant leadership and service by maintaining non-profit board roles for many organizations including CALHIPSO and others focused on the pipeline of underrepresented youth getting into the full spectrum of health careers. She received her BS in Biochemistry from Clark Atlanta University in Atlanta, Georgia, her Masters Degree in Public Health in Epidemiology and Health Systems from the University of Washington and spent time at Boston University School of Medicine.

Kirsten works with leaders in life sciences companies to navigate policy, competition, reimbursement and public perception for successful product launch, growth and for profitability. She has diverse experience developing and executing strategy at all stages of the biopharmaceutical lifecycle and in all major markets. Now an independent consultant and non-profit founder, Kirsten previously was on the leadership team of Pfizer Inc’s $30 billion global innovative pharmaceutical business. She led Strategy and Business Evaluation for Rare Disease, Oncology, Inflammation & Immunology and Primary Care. Kirsten also led Pfizer’s Global Policy team. She founded and is the Secretary of the Preparedness and Treatment Equity Coalition. She is also a visiting scholar with the American Enterprise Institute, an Aspen Institute Health Fellow and a senior advisor to DLA Piper. Kirsten is a board member for Ramapo for Children and Aequitas Health, worked in Ethiopia with the International Trachoma initiative and climbed Mt. Kilimanjaro with other healthcare leaders to raise $1.6 million for the Fred Hutchinson Cancer Center.

Tanisha Carino is a corporate affairs and health policy expert, bringing over 20 years of experience across multiple healthcare leadership positions in government, private, and non-profit sectors. Tanisha provides strategic counsel at the highest levels of the public and private sectors, employing her rare combination of business strategy, government affairs, and stakeholder management. Prior to joining Brunswick, Tanisha held executive roles as the first Chief Corporate Affairs Officer of Alexion, Executive Director of FasterCures/Milken Institute, led US public policy at GlaxoSmithKline, and was the head of life sciences strategic advisory services for Avalere Health. She began her career as an HIV case worker in Atlanta and a policy researcher in the Medicare program. Dr. Carino is a Fulbright Fellow, has served as a Visiting Fellow for the White House Office of Science and Technology Policy, and earned her Ph.D. in health policy from Johns Hopkins University. She is associate faculty at the Johns Hopkins Bloomberg School of Public Health, a Visiting Fellow for the Duke-Margolis Health Policy Center, serves on the Board of Directors of Silk Road Medical, One Mind, and is the Vice-Chair of the Alliance for Health Policy.

Daniela Lawton, MPH, is an Assistant Director in the Research and Analysis Department at the National Committee for Quality Assurance (NCQA). Her work primarily focuses on measure development for individuals with chronic conditions. In her current position, Daniela directs the implementation and development of the person-centered outcome measures, measures focused on identifying what matters most to an individual and incorporating their goals into care planning and quality measurement. She has extensive knowledge in measure implementation, testing and clinician training as well as managing and leading complex projects for foundations, corporations and state Medicaid departments. Daniela received her bachelor’s degree in Life Science from Pennsylvania State University and her master’s degree in public health from George Washington University.